Literature DB >> 22128144

Nab2 regulates secondary CD8+ T-cell responses through control of TRAIL expression.

Monika C Wolkers1, Carmen Gerlach, Ramon Arens, Edith M Janssen, Patrick Fitzgerald, Ton N Schumacher, Jan Paul Medema, Douglas R Green, Stephen P Schoenberger.   

Abstract

CD4(+) Th cells are pivotal for the generation and maintenance of CD8(+) T-cell responses. "Helped" CD8(+) T cells receive signals during priming that prevent the induction of the proapoptotic molecule TNF-related apoptosis-inducing ligand (TRAIL) during reactivation, thereby enabling robust secondary expansion. Conversely, "helpless" CD8(+) T cells primed in the absence of Th induce TRAIL expression after restimulation and undergo activation-induced cell death. In the present study, we investigated the molecular basis for the differential regulation of TRAIL in helped versus helpless CD8(+) T cells by comparing their transcriptional profiles, and have identified a transcriptional corepressor, NGFI-A binding protein 2 (Nab2), that is selectively induced in helped CD8(+) T cells. Enforced expression of Nab2 prevents TRAIL induction after restimulation of primary helpless CD8(+) T cells, and expression of a dominant-negative form of Nab2 in helped CD8(+) T cells impairs their secondary proliferative response that is reversible by TRAIL blockade. Finally, we observe that the CD8(+) T-cell autocrine growth factor IL-2 coordinately increases Nab2 expression and decreases TRAIL expression. These findings identify Nab2 as a mediator of Th-dependent CD8(+) T-cell memory responses through the regulation of TRAIL and the promotion of secondary expansion, and suggest a mechanism through which this operates.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22128144      PMCID: PMC3265202          DOI: 10.1182/blood-2011-08-373910

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  41 in total

1.  Epigenetic remodeling of the IL-2 and IFN-gamma loci in memory CD8 T cells is influenced by CD4 T cells.

Authors:  John K Northrop; Rajan M Thomas; Andrew D Wells; Hao Shen
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

2.  Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection.

Authors:  Vladimir P Badovinac; Jodie S Haring; John T Harty
Journal:  Immunity       Date:  2007-06-07       Impact factor: 31.745

3.  Cutting edge: CD4+ T cell-derived IL-2 is essential for help-dependent primary CD8+ T cell responses.

Authors:  Elizabeth B Wilson; Alexandra M Livingstone
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

4.  CD4+ T cell help improves CD8+ T cell memory by retained CD27 expression.

Authors:  Matthias S Matter; Christina Claus; Adrian F Ochsenbein
Journal:  Eur J Immunol       Date:  2008-07       Impact factor: 5.532

5.  Cutting Edge: TCR-induced NAB2 enhances T cell function by coactivating IL-2 transcription.

Authors:  Samuel Collins; Lawrence A Wolfraim; Charles G Drake; Maureen R Horton; Jonathan D Powell
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

6.  IL-15 as a mediator of CD4+ help for CD8+ T cell longevity and avoidance of TRAIL-mediated apoptosis.

Authors:  Sangkon Oh; Liyanage P Perera; Masaki Terabe; Ling Ni; Thomas A Waldmann; Jay A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-24       Impact factor: 11.205

7.  Cutting edge: chromatin remodeling as a molecular basis for the enhanced functionality of memory CD8 T cells.

Authors:  John K Northrop; Andrew D Wells; Hao Shen
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

8.  BioMart Central Portal--unified access to biological data.

Authors:  Syed Haider; Benoit Ballester; Damian Smedley; Junjun Zhang; Peter Rice; Arek Kasprzyk
Journal:  Nucleic Acids Res       Date:  2009-05-06       Impact factor: 16.971

9.  CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help.

Authors:  Yusuke Nakanishi; Bao Lu; Craig Gerard; Akiko Iwasaki
Journal:  Nature       Date:  2009-11-08       Impact factor: 49.962

10.  Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells.

Authors:  Andrew M Intlekofer; Naofumi Takemoto; Charlly Kao; Arnob Banerjee; Felix Schambach; John K Northrop; Hao Shen; E John Wherry; Steven L Reiner
Journal:  J Exp Med       Date:  2007-08-13       Impact factor: 14.307

View more
  14 in total

Review 1.  Asymptomatic memory CD8+ T cells: from development and regulation to consideration for human vaccines and immunotherapeutics.

Authors:  Arif Azam Khan; Ruchi Srivastava; Patricia Prado Lopes; Christine Wang; Thanh T Pham; Justin Cochrane; Nhi Thi Uyen Thai; Lucas Gutierrez; Lbachir Benmohamed
Journal:  Hum Vaccin Immunother       Date:  2014-02-05       Impact factor: 3.452

2.  Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer.

Authors:  Anusha-Preethi Ganesan; James Clarke; Oliver Wood; Eva M Garrido-Martin; Serena J Chee; Toby Mellows; Daniela Samaniego-Castruita; Divya Singh; Grégory Seumois; Aiman Alzetani; Edwin Woo; Peter S Friedmann; Emma V King; Gareth J Thomas; Tilman Sanchez-Elsner; Pandurangan Vijayanand; Christian H Ottensmeier
Journal:  Nat Immunol       Date:  2017-06-19       Impact factor: 25.606

Review 3.  Sepsis-Induced T Cell Immunoparalysis: The Ins and Outs of Impaired T Cell Immunity.

Authors:  Isaac J Jensen; Frances V Sjaastad; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2018-03-01       Impact factor: 5.422

4.  Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression.

Authors:  Benjamin J Schmiedel; Divya Singh; Ariel Madrigal; Alan G Valdovino-Gonzalez; Brandie M White; Jose Zapardiel-Gonzalo; Brendan Ha; Gokmen Altay; Jason A Greenbaum; Graham McVicker; Grégory Seumois; Anjana Rao; Mitchell Kronenberg; Bjoern Peters; Pandurangan Vijayanand
Journal:  Cell       Date:  2018-11-15       Impact factor: 41.582

Review 5.  The multifaceted role of CD4(+) T cells in CD8(+) T cell memory.

Authors:  Brian J Laidlaw; Joseph E Craft; Susan M Kaech
Journal:  Nat Rev Immunol       Date:  2016-01-19       Impact factor: 53.106

6.  Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity.

Authors:  Arnab Ghosh; Yildirim Dogan; Maxim Moroz; Amanda M Holland; Nury L Yim; Uttam K Rao; Lauren F Young; Daniel Tannenbaum; Durva Masih; Enrico Velardi; Jennifer J Tsai; Robert R Jenq; Olaf Penack; Alan M Hanash; Odette M Smith; Kelly Piersanti; Cecilia Lezcano; George F Murphy; Chen Liu; M Lia Palomba; Martin G Sauer; Michel Sadelain; Vladimir Ponomarev; Marcel R M van den Brink
Journal:  J Clin Invest       Date:  2013-05-15       Impact factor: 14.808

7.  Trauma patients' elevated tumor necrosis related apoptosis inducing ligand (TRAIL) contributes to increased T cell apoptosis.

Authors:  Gautam Bandyopadhyay; Paul E Bankey; Carol L Miller-Graziano
Journal:  Clin Immunol       Date:  2012-08-03       Impact factor: 3.969

Review 8.  Therapeutic applications of TRAIL receptor agonists in cancer and beyond.

Authors:  Gustavo P Amarante-Mendes; Thomas S Griffith
Journal:  Pharmacol Ther       Date:  2015-09-05       Impact factor: 12.310

Review 9.  T-cell-mediated immunity and the role of TRAIL in sepsis-induced immunosuppression.

Authors:  Stephanie A Condotta; Javier Cabrera-Perez; Vladimir P Badovinac; Thomas S Griffith
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

10.  Neem leaf glycoprotein activates CD8(+) T cells to promote therapeutic anti-tumor immunity inhibiting the growth of mouse sarcoma.

Authors:  Atanu Mallick; Subhasis Barik; Kuntal Kanti Goswami; Saptak Banerjee; Sarbari Ghosh; Koustav Sarkar; Anamika Bose; Rathindranath Baral
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.